Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-08

Clinical Trial Update: Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating topiramate, amitriptyline as monotherapy and in combination for migraine prophylaxis; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)
  • amitriptyline (amitriptyline)

Snippet

Sponsor: Dr. Reaz Mahmud | Conditions: Migraine | Phase 4 | Status: UNKNOWN